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Introduction
Nowadays, there are increased opportunities for 
diagnostic assessment and treatment of SNHL. In 
most of the cases, hearing loss has a multifactorial 
genesis, the causes being both genetic and resulting 
from environmental factors. A gene mutation can 
lead to hearing loss. In these cases hearing loss is 
a monogenetic disorder with autosomal dominant, 
autosomal recessive, X-linked or mitochondrial 
inheritance. 
Hearing loss can be classified as genetic or non-ge-
netic, depending on the presence of coding muta-
tions; depending on the time of occurrence it can 
be prelingual or postlingual;  and syndromic (a 
combination of hearing loss and one or more other 
specific anomalies) or non-syndromic. 
Dozens of genetic loci have been identified as the 
reason for syndromic and non-syndromic hearing 
loss with various models of inheritance (autosomal 
dominant, autosomal recessive, X-linked, mito-
chondrial). The prelingual sensorineural hearing 
loss is estimated at 1 in 500 children in developed 
countries as in 80% of the cases hearing loss is 
genetic. About 80% of the affected have non-syn-
dromic hearing loss while the remaining 20% - 
syndromic. In 80% of the cases the  non-syndromic 
hearing loss is inherited in a recessive pattern, in 
19% the inheritance is autosomal dominant and in 
less than 1% the modes of inheritance are mito-
chondrial, miRNA and Х- linked [1]. 
The main goal of our study is to provide an identi-
fication strategy of the genetic causes and to refer 
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alter the gap junctions, which causes disruption in 
the levels of potassium ions in the inner ear.  
The screening continued with searching for muta-
tions in the genes GJB6 and GJB3, encoding pro-
teins connexin 30 and connexin 31 respectively. 
Among the 192 study patients, mutation of the gene 
encoding Сх30 was not found, which is not unusual 
in view of its low frequency in the population – 
0.65% [2]. Mutations in Сх31 were not identified 
either. 
As a next step in diagnosing hereditary hearing 
loss, we introduced the application of targeted 
next-generation sequencing [Figure 1]. We selected 
families where several members of different gener-
ations were affected by SNHL and our aim was to 
identify rare mutations in genes encoding hearing. 
the patient to the most effective treatment.  For 
the purposes of implementing that goal, a genetic 
screening algorithm was developed (Figure 1).
During the screening of the study participants, 
a mutation in GJB2, the gene encoding protein 
connexin 26 was identified, as the frequency was 
43.75%. In 29.69% of the cases, it involved mutant 
alleles in a homozygous state, while in 14.06% of 
the cases mutations were in a heterozygous state. 
Mutations in the GJB2 gene are the most frequent 
cause of monogenic hearing loss, responsible for 
about half of all the cases of autosomal recessive 
prelingual hearing loss. It is inherited in an autoso-
mal recessive pattern, which means that two copies 
of the GJB2 gene have to be changed in each cell to 
cause a hearing impairment. Mutations in this gene 
Genetic screening algorithm
Figure 1. Genetic screening algorithm�
Screening for mutations in Cx26
Screening for mutations in Cx30 – all patients with a recessive mutation in the 
heterozygous state or those with no identified mutation in Cx26
Screening for mutations in Cx31 - all patients with only one identified recessive mutation 
in the heterozygous state in Cx26 or Cx30 and all patients with no identified mutation
When the mutations causing 
deafness are identified
When mutations causing 
deafness are identified
When mutations causing 
deafness are identified
If  no mutation is identified or 
a recessive mutation in the 
heterozygous state is found
If  no mutation is identified or 
a recessive mutation in the 
heterozygous state is found
If  no mutation is identified or 
a recessive mutation in the 




Targeted next-generation sequencing – all patients in who no mutation was found during 
the screening for common mutations (in Сх26, Сх30 and Сх31), causing deafness�
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fied themselves as Bulgarians, 16.15% (n = 31) as 
Roma, 5.73% (n = 11) as Turks and 4.69% (n = 9) 
came from mixed marriages.
According to the Bulgarian standards 55.73% (n= 
107) of the study patients had deafness, 18.75% 
(n= 36) of them were with severe deafness (hear-
ing loss between 60 and 90 dB), 18.3% (n= 35) 
with moderate (hearing loss from 30 to 60 dB), 
and 7.9% (n= 14) of the subjects had normal 
hearing.
Methods
For the purposes of the genetic testing DNA was 
isolated with CHEMAGEN® magnetic separation 
station. The aim of the isolation was to receive high 
molecular weight DNA with minimal impurities 
such as protein, RNA and glycoproteins. A new 
trend in the methods for isolation of high molecular 
weight DNA is through automated magnetic sepa-
ration, which was used in this study.  
The quality of the received high molecular weight 
DNA was defined through agarose gel electro-
phoresis using 0.8% agarose gel and 1хТВЕ (tris, 
borate, EDTA buffer). Concentration of the isolated 
DNA was estimated with the spectrophotometer 
NanoDropTM. 
To perform the targeted next-generation sequenc-
ing we used TruSight One Kit for the preparation 
and the platform MiSeq, Illumina for the sequenc-
ing. Preparation of the libraries was done according 
to the manufacturer’s requirements. [Figure 2]
Due to the substantial genetic heterogeneity of 
deafness, the clinical application of genetic infor-
mation is still leading to a number of difficulties. It 
is known that more than 80 genes are related to the 
non-syndromic hereditary hearing loss. Progress 
in targeted exome sequencing of selected genes, 
using massively parallel DNA sequencing allows 
the successful identification of relatively rare gene 
mutations [3].
Materials and methods
The study included 192 patients: 178 of them with 
sensorineural hearing loss and 14 subjects with 
normal hearing, relatives of the study patients with 
impaired hearing, of who biological material was 
also taken to look for mutations associated with 
hearing. 
According to anamnestic data in 54.17 % (n = 104) 
of the cases hearing loss occurred prelingually, 
before development of speech, in 38.54% (n = 74) 
of the cases postlingually, after acquiring speech 
and 7.29% (n = 14) of the cases had socially ade-
quate hearing ability.
The diagnosis was established through pure-tone 
threshold audiometry of all participants over 6 
years of age.  Play audiometry was performed in 
patients between the age of 3 and 6 and for chil-
dren younger than 3, BAEPs were used. Otoscopy, 
tympanometry and reflexometry were performed in 
all participants.  
When selecting the patients the following criteria 
were met:
 – Patients were studied regardless of their age, 
gender and ethnicity;
 – Enrolled patients had bilateral sensorineural 
hearing loss, irrespective of the degree of hear-
ing loss;
 – The study also included normally hearing sub-
jects with a family history of SNHL;
 – All study participants have a normal ENT status 
and respectively normal middle ear pressure;
 – Patients with syndromic sensorineural hearing 
loss were not studied;
 – In studied patients, hearing impairments caused 
by exogenous factors such as craniocerebral 
trauma, noise trauma, exposure to loud noise 
were excluded.
The mean age of the study participants was 20.4 
years, the youngest being two-months old and the 
oldest one - 70 years old.
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And Exon Definition Analyses http://splice.uwo.
ca/, NetGene2 http://www.cbs.dtu.dk/services/Net-
Gene2/, Human Splicing Finder http://www.umd.
be/HSF3/HSF.html .
Results
From the 192 study patients, in 31.77% (n = 61) a 
mutation causing hearing loss was identified while 
in 68.23% (n = 131) of the cases the reason for hear-
ing loss remained unclear. After performing genetic 
tests in 43.75% (n = 84) of the cases, a mutation 
in GJB2 was identified, the gene encoding protein 
connexin 26, as this percentage included both het-
erozygous and homozygous mutations. In 2.08% 
(n= 4) of the cases mutations causing hearing loss 
were found in genes other than connexin genes. In 
54.17% (n = 104) no mutations involved in hearing 
were identified. [Figure 3]
In 29.69% (n = 57) of the tested patients, it was 
found that the hearing loss is caused by a homozy-
gous mutation in the gene encoding protein Cx26. 
In 14.06% (n = 27) of the study group, mutations 
were identified in the gene encoding protein Cx26 
in a heterozygous state.  In those patients, the 
reason for the hearing loss remained undefined. 
In 2.08% (n= 4) of the cases mutations causing 
hearing loss were found in genes other than GJB2 
gene. In 54.17% (n = 104) of the tested the reason 
for hearing loss was not identified. [Figure 4]
In 57.89% (n = 110) of the cases the hearing loss 
Bioinformatics methods 
The obtained data was processed with VarSeq® 
(Golden Helix, Inc., Bozeman, MT, www.golden-
helix.com), a software package, and the analysis 
included: 
 – Alignment and mapping of reads to the human 
reference genome HG19; 
 – Removal of duplicate reads, indel realignment 
and base quality score recalibration (BQSR);
 – Identification of human reference genome var-
iants;
 – Annotation of public databases on population 
frequencies, position in the corresponding pro-
tein and mRNA, pathogenicity predictions, evo-
lutionary conservatism, etc;
 – Prioritizing the identified variants through fil-
tering.
The functional impact of the candidate muta-
tions was assessed in silico, using prediction 
programmes to determine the possible phenotypic 
impact on the variant.  For predicting the effect of 
missense mutations, the following tools were used: 
SIFT http://sift.jcvi.org/ , Polyphen-2 http://genet-
ics.bwh.harvard.edu/pph2/ , MutationTaster  http://
www.mutationtaster.org/ , Meta-SNP http://snps.
biofold.org/meta-snp/, MutationAssessor (muta-
tionassessor.org), Provean (provean.jcvi.org), LRT 
(Chun and Fay, 2009), VEST 3 (Carter H. et al, 
2013), MetaSVM; for variants potentially leading 
to changes in the splicing: Automated Splice Site 
Figure 3: Types of  genetic mutations in the study�
Mutations in GJB2 gene
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A comparison was made of the presence of a 
genetic mutation in patients of Bulgarian, Turk-
ish, Roma and mixed ethnic origin and the results 
did not show statistical significance – р = 0.217. 
Mutations in genes causing a hearing impairment 
were distributed regardless of the ethnic origin. 
[Figure 5]
Statistical significance was found (р < 0.05) 
between the presence of mutations in the genes 
responsible for hearing and the onset of the hearing 
impairment.  Comparing the group of patients with 
hearing loss caused by a mutation with the group 
had no progression; patients with prelingual hear-
ing loss belonged to that group.  In the remaining 
42.11% (n = 80) of the cases hearing deteriorated 
over time. When comparing progression of hearing 
loss with regard to the impairment onset, it can be 
seen that the lack of progress in the hearing impair-
ment in cases of prelingual deafness, i.e. 50.57% (n 
= 89), dominated over the presence of progression 
found in 7.39% of the cases. Progression in hearing 
loss dominated in the postlingual impairment – in 
36.93 % (n = 65) over the lack of progression – in 
5.11% of the cases.
Figure 4: Types of  genetic mutations in the study�
Figure 5. Genetic mutations based on ethnicity�
Homozygous and heterozygous mutations in GJB2 gene
No mutation identified
Identified mutation causing  
the hearing loss
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ated with degenerative processes that have been 
observed in many other genetic diseases affecting 
the nervous system. Therefore, hearing loss in 
patients with mutations in that gene progresses and 
inheritance in them is autosomal dominant.
Discussion
Among the Bulgarian population, the most com-
mon mutation in gene GJB2 is c.35delG, found in 
43.75% of the study patients with SNHL: 29.69% 
in a homozygous state and in 14.06% of the cases 
in a heterozygous. It was identified in patients 
from Bulgarian and Turkish ethnic origin but not 
in patients from the Roma ethnic group. Carrier 
frequency of different mutations in GJB2 differs 
globally.
According to literature data and in conclusion 
from our experience with the study group of 
patients with SNHL, genetic testing must start 
with search of mutations in the GJB2 gene, as the 
most common cause of deafness in the Bulgarian 
population.  Therefore screening for mutations 
among the study participants started with Сх26 
gene. Ethnic origin plays an important role in the 
distribution and frequency of mutations, as it is 
clear from the obtained results in Ashkenazi Jews 
(167 delT), Asians (23delC), Caucasians (35delG). 
These observations were confirmed by our results 
as well.  In the Bulgarian population, among the 
of patients without identified mutations in genes 
involved in hearing, predominance of prelingual 
hearing loss was observed in patients with proven 
genetic deafness. In patients with no identified 
mutations, the distribution between prelingual and 
postlingual onset of the hearing impairment was 
approximately the same. [Figure 6]
Among the selected five families who underwent 
targeted next-generation sequencing,   no probrand 
was a carrier of mutations in Cx26 (GJB2), Cx30 
(GJB6) and Cx31 (GJB3) [Figure 7]. After per-
forming the targeted next-generation sequencing 
among the selected families, interesting results 
were received for all who were expected to have 
gene mutations responsible for hearing. In families: 
№1, №2 and №4, no currently known mutations 
were identified in genes associated with hearing.
In family №3, through CNV analysis, in the test-
ed patient a duplication of 51 base pairs in the 
OTOA gene was found (16:21679026-21679076), 
affecting exon 3 and partially intron 1-2 and intron 
2-3. CNVs have been increasingly associated with 
non-syndromic hearing loss [4]. 
In family №5 the replacement, p.Gly285Ser, is 
a mutation leading to loss of functions and has a 
strong dominant-negative effect on the wild type 
KCNQ4 channels [5]. It has been proven that in 
Xenopus oocytes the mutation leads to lack of К+ 
currents [6]. Dysfunction of KCNQ4 is associ-
Figure 6. Presence of  genetic mutation in connection with the hearing loss onset
Prelingual onset
Postlingual onset
Presence of  mutation causing 
the hearing loss
No mutation identified
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Figure 7. Family trees of  the studied families� In family №1 probrand is DF60; in family № 2 probrand is DF84; in family № 
3 probrand is DF139; in family № 4 – DF182; in family № 5 – DF210�
tested Roma group with SNHL a high frequency 
of mutation p.W24X in a homozygous state was 
observed. 
As a next step in diagnosing hereditary hearing 
loss, following the screening for mutations in 
connexin genes, we introduced the use of targeted 
next-generation sequencing in patients in whom 
such mutation was not found or it was in a hete-
rozygous state.  
We selected families where several members of 
different generations had SNHL and our aim was 
to identify rare mutations in genes responsible for 
hearing. After performing the targeted next-gen-
eration sequencing among the selected families, 
interesting results were received for all who were 
expected to have gene mutations responsible for 
hearing.
In family №3, in the tested probrand, through 
CNV analysis, a duplication of 51 base pairs in the 
OTOA gene (16:21679026-21679076) was found, 
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at the age of 3 months. Currently in literature, 
there are no described cases of carriers of muta-
tion c.853G>A (p.Gly285Ser), with a congenital 
hearing impairment. In that girl, the presence of 
a variant in another gene or the same gene might 
have aggravated the clinical phenotype. 
Conclusion
Hearing screening in order to identify deafness 
needs to start in neonatal units within 48 hours after 
birth. An important step is referring the child to an 
audiologist in case negative OAEs are registered. 
The next step is BAEP testing. 
Hearing loss is the only sensory deficit, which can 
be successfully treated even with regard to pro-
found deafness. Cochlear implants have a positive 
effect in speech production and speech perception. 
A significant positive change in cognitive ability 
and reading is achieved, strongly expressed in chil-
dren with GJB2 mutation, which causes an isolated 
impairment in the cochlea without impairment of 
cranial nerve VIII or the CNS. 
affecting exon 3 and partially intron 1-2 and intron 
2-3. 
In family №5 the replacement, p.Gly285Ser, is a 
mutation leading to loss of functions. The hear-
ing loss progresses in patients with mutations in 
that gene. Inheritance in them is autosomal dom-
inant. Cases of autosomal recessive inheritance 
have also been reported in carriers of mutations 
in KCNQ4. Wasano K. et al reported on a family 
with autosomal recessive form of non-syndromic 
hearing loss who had mutation c.1044_1051del8 in 
a homozygous state. The probrand was diagnosed 
with severe hearing loss that was either congenital 
or with an onset in early childhood. The probrand’s 
daughter was a heterozygous carrier of the muta-
tion but she had no hearing impairment [Wasano 
K. et al, 2015].
The found variant in KCNQ4 co-segregated with 
the disease in the family and explained the occur-
rence of the hearing loss. Mutations in that gene 
have been associated with progressive hearing 
loss with a postlingual onset.   In the probrand’s 
daughter the hearing impairment was diagnosed 
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